ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years
Constantinos Pantelis Zambirinis
Matched on ORCID iD 0000-0003-2740-3259; OpenAlex author ID A5044844359. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 34
2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: 3 papers · 2023: none · 2024: 1 paper
Papers 9
- Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer. First author DOI 10.1038/s41591-024-03075-7↗
- Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? Co-author DOI 10.1245/s10434-022-11579-0↗
- ASO Author Reflections: Predicting Pancreatic Cancer Liver Metastasis by Integrating Primary Tumor Clinicopathologic Features and Liver Radiomics. Co-author DOI 10.1245/s10434-022-11653-7↗
- The Liver Pre-Metastatic Niche in Pancreatic Cancer: A Potential Opportunity for Intervention. Last author DOI 10.3390/cancers14123028↗
- Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancrea… Co-author DOI 10.1016/j.hpb.2017.12.010↗
- The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Co-author DOI 10.1158/2159-8290.cd-17-1134↗
- Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer. Co-author DOI 10.1016/j.molmed.2017.03.003↗
- TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia. Co-author DOI 10.1371/journal.pone.0132786↗
- Pancreatic cancer, inflammation, and microbiome. Co-author DOI 10.1097/ppo.0000000000000045↗
Closest collaborators
The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- William R. Jarnagin · 3 shared papers, 2018–2022 · strength 0.52
- Paper ASO Author Reflections: Predicting Pancreatic Cancer Liver Metastasis by Integrating Primary Tumor Clinicopathologic Fe… DOI 10.1245/s10434-022-11653-7↗
- Paper Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? DOI 10.1245/s10434-022-11579-0↗
- Paper Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct… DOI 10.1016/j.hpb.2017.12.010↗
- George Miller · 4 shared papers, 2014–2018 · strength 0.30
- Paper Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer. DOI 10.1016/j.molmed.2017.03.003↗
- Paper Pancreatic cancer, inflammation, and microbiome. DOI 10.1097/ppo.0000000000000045↗
- Paper The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. DOI 10.1158/2159-8290.cd-17-1134↗
- Linda Bojmar · 2 shared papers, 2018–2022 · strength 0.27
- Peter Gumberger · 1 shared paper, 2022 · strength 0.20
- Bergþór Björnsson · 1 shared paper, 2022 · strength 0.20
- T. Peter Kingham · 2 shared papers, 2018–2022 · strength 0.19
- Paper Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? DOI 10.1245/s10434-022-11579-0↗
- Paper Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct… DOI 10.1016/j.hpb.2017.12.010↗
- Michael Ian D'Angelica · 2 shared papers, 2018–2022 · strength 0.19
- Paper Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? DOI 10.1245/s10434-022-11579-0↗
- Paper Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct… DOI 10.1016/j.hpb.2017.12.010↗
- Jian Zheng · 2 shared papers, 2018–2022 · strength 0.19
- Paper Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? DOI 10.1245/s10434-022-11579-0↗
- Paper Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct… DOI 10.1016/j.hpb.2017.12.010↗
- Peter J. Allen · 2 shared papers, 2018–2022 · strength 0.19
- Paper Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? DOI 10.1245/s10434-022-11579-0↗
- Paper Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct… DOI 10.1016/j.hpb.2017.12.010↗
- Vinod P. Balachandran · 1 shared paper, 2022 · strength 0.13
- Caitlin A. McIntyre · 1 shared paper, 2022 · strength 0.13
- Jeffrey A. Drebin · 1 shared paper, 2022 · strength 0.13
- Jayasree Chakraborty · 1 shared paper, 2022 · strength 0.13
- Richard Kinh Gian Do · 1 shared paper, 2022 · strength 0.13
- Amber L. Simpson · 1 shared paper, 2022 · strength 0.13
- Deepak Saxena · 2 shared papers, 2014–2018 · strength 0.11
- Smruti Pushalkar · 2 shared papers, 2014–2018 · strength 0.11
- Donnele Daley · 2 shared papers, 2015–2018 · strength 0.09
- Paper The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. DOI 10.1158/2159-8290.cd-17-1134↗
- Paper TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia. DOI 10.1371/journal.pone.0132786↗
- Alejandro Torres-Hernandez · 2 shared papers, 2015–2018 · strength 0.09
- Paper The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. DOI 10.1158/2159-8290.cd-17-1134↗
- Paper TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia. DOI 10.1371/journal.pone.0132786↗
- Olca Baştürk · 1 shared paper, 2018 · strength 0.06
- Jonathan Matthew Hernandez · 1 shared paper, 2018 · strength 0.06
- Bruno Costa‐Silva · 1 shared paper, 2018 · strength 0.06
- Gökçe Aşkan · 1 shared paper, 2018 · strength 0.06
- David Charles Lyden · 1 shared paper, 2018 · strength 0.06
- Alexandre Doussot · 1 shared paper, 2018 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.